LGVN
Longeveron Inc - Ordinary Shares - Class A

12,985
Mkt Cap
$20.77M
Volume
13.55M
52W High
$1.92
52W Low
$0.475
PE Ratio
-0.73
LGVN Fundamentals
Price
$0.9735
Prev Close
$0.809
Open
$0.851
50D MA
$0.582
Beta
0.96
Avg. Volume
438,963.23
EPS (Annual)
-$2.62
P/B
2.06
Rev/Employee
$92,000.00
$1.50
Loading...
Loading...

About

Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
26

Frequently Asked Questions

What is Market Cap of Longeveron Inc - Ordinary Shares - Class A?
What is the 52-week high for Longeveron Inc - Ordinary Shares - Class A?
What is the 52-week low for Longeveron Inc - Ordinary Shares - Class A?
What is Longeveron Inc - Ordinary Shares - Class A stock price today?
What was Longeveron Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Longeveron Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Longeveron Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Longeveron Inc - Ordinary Shares - Class A?
How many employees does Longeveron Inc - Ordinary Shares - Class A have?

Latest LGVN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.